A trial of nilotinib for children and young people with Philadelphia positive leukaemia

Overview

Cancer types:

Acute leukaemia, Blood cancers, Children's cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia

Status:

Results

Phase:

Phase 1

Details

This trial looked at nilotinib for children and young people whose leukaemia had the . It was for children who had:

just been diagnosed with chronic myeloid leukaemia (CML)
CML that wasn’t responding to drugs called imatinib or dasatinib
acute lymphoblastic leukaemia (ALL) that had got worse or came back despite having other treatment

The trial was for children and young people up to the age of 18. We use the term ‘you’ in this summary, but if you are a parent, we are referring to your child.

This trial was open for people to join between 2011 and 2014. The team published the results in 2020.

Recruitment start: 13 April 2011

Recruitment end: 1 October 2014